ArticleBundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz2025
[Development of cannabis use from adolescence to young adulthood and risk and protective factors for problematic use-results of a longitudinal study].
Article in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-Traumatic Stress in Adolescence: The Mediating Role of Time Perspective Between Trauma Exposure, PTSD Symptoms, and Cannabis Use.European journal of investigation in health, psychology and education · 2025Article
- Cannabis use among adolescents and young adults in Germany: Study results and prevention measures offered by the Federal Institute of Public Health.Journal of health monitoring · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOn April 1, 2024, the new cannabis law came into force, legalizing the use of cannabis in Germany. Even before, Cannabis had been one of the most commonly used drugs. However, problematic cannabis use is related to a variety of health risks especially for adolescents and young adults. This study examines the development of cannabis use from adolescence to young adulthood as well as risk and protective factors for problematic use among young adults.
methodsThe data come from the German longitudinal study "Future Family" (Start: 2001; 18-year follow-up: 2020-22). The sample includes N = 278 young adults (M = 22.3 years). Prevalence rates and the development of cannabis use from adolescence to young adulthood are analyzed. Various child- and family-related variables from early childhood and adolescence are examined as potential risk and protective factors for problematic cannabis use.
resultsThe lifetime prevalence of cannabis use was 57.6%, and the prevalence of problematic use was 13.7%. Young men had a 3.3 times higher risk of problematic cannabis use compared to young women. Young adults who had already used cannabis at least once in their youth when surveyed had a 2.6 times higher risk of problematic use in young adulthood. The extent of mother-reported externalizing behavior problems in adolescence significantly predicted problematic use eight years later. DISCUSSION: The results confirm that cannabis use and problematic use in young adulthood were not a rare phenomenon even before legalization. They highlight the need for both conditional and behavioral preventive actions and provide numerous starting points for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.